Literature DB >> 8095994

The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal.

J Gelernter1, D Goldman, N Risch.   

Abstract

OBJECTIVE: An allelic association between the TaqI "A" system A1 allele at the D2 dopamine receptor locus (DRD2) and either alcoholism or severe alcoholism has been proposed. Our purpose was to evaluate whether, based on all of the accumulated evidence, this association could be considered to be proven. DATA SOURCES: We considered data from all published reports of DRD2 allele frequency in alcoholics, controls, or both. STUDY SELECTION: We concentrated on the issue of replication. We therefore considered all data reported (on white samples, because DRD2 allele frequency varies by race and ethnicity) since the first report by Blum et al in 1990. DATA SYNTHESIS: We analyzed the set of data for differences in allele frequencies between alcoholics and controls, and for heterogeneity among samples. We also investigated the influence of the data from the first group to report an association (including a subsequent report from that group) on the findings. Our analysis shows that, when all studies subsequent to the original study are considered, there is no significant difference in DRD2 A1 allele frequency between alcoholics and controls, there is significant heterogeneity among reported alcoholics and reported controls, and there is no significant difference in DRD2 A1 allele frequency between severe and not severe alcoholics. Also, the two reports of Blum et al account for all of the (nonsignificant) differences seen between controls, alcoholics, and severe alcoholics.
CONCLUSIONS: In general, heterogeneity among studies (for alcoholics or controls) is considerably greater than differences between alcoholics and controls overall. The findings to date can best be explained by more conservative interpretations than a confirmed physiologically important allelic association between DRD2 alleles and alcoholism. These other possibilities include sampling error and ethnic variation in those studies that individually showed a large effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095994

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  29 in total

1.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

2.  Spouses and unrelated friends of probands as controls for stroke genetics studies.

Authors:  Bradford Burke Worrall; Devin L Brown; Thomas G Brott; Robert D Brown; Scott L Silliman; James F Meschia
Journal:  Neuroepidemiology       Date:  2003 Jul-Aug       Impact factor: 3.282

3.  Genetic association analysis using data from triads and unrelated subjects.

Authors:  Michael P Epstein; Colin D Veal; Richard C Trembath; Jonathan N W N Barker; Chun Li; Glen A Satten
Journal:  Am J Hum Genet       Date:  2005-02-14       Impact factor: 11.025

4.  The misuse of behavioral genetics in prevention research, or for whom the "bell curve" tolls.

Authors:  W S Poston; A A Winebarger
Journal:  J Prim Prev       Date:  1996-09

Review 5.  Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence.

Authors:  M Virkkunen; D Goldman; D A Nielsen; M Linnoila
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

6.  The conflict between public health goals and the temperance mentality.

Authors:  S Peele
Journal:  Am J Public Health       Date:  1993-06       Impact factor: 9.308

7.  Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett
Journal:  Hum Genet       Date:  2009-02-01       Impact factor: 4.132

8.  STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett
Journal:  PLoS Med       Date:  2009-02-03       Impact factor: 11.069

9.  STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett
Journal:  Eur J Clin Invest       Date:  2009-04       Impact factor: 4.686

Review 10.  Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett
Journal:  Eur J Epidemiol       Date:  2009-02-03       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.